Literature DB >> 24930647

Characteristics of tuberculosis in patients with rheumatoid arthritis: a retrospective single-center study.

Takashi Ishiguro1, Noboru Takayanagi, Naho Kagiyama, Tsutomu Yanagisawa, Yutaka Sugita.   

Abstract

OBJECTIVE: The objective of this study was to assess the characteristics of hospitalized patients suffering from tuberculosis with rheumatoid arthritis (RA), focusing specifically on those treated without anti-tumor necrosis factor (TNF) therapy.
METHODS: We conducted a retrospective review to assess the characteristics of 1,022 hospitalized Japanese patients suffering from tuberculosis with and without RA between 2002 and 2011.
RESULTS: Compared with the 995 non-RA patients with tuberculosis, the 24 RA patients with tuberculosis treated without anti-TNF therapy were older and predominantly female. They less frequently had a history of smoking, with a higher rate of underlying respiratory diseases, an impaired performance status and side effects. The three RA patients receiving anti-TNF therapy had extrapulmonary tuberculosis; however, the rate of extrapulmonary tuberculosis in the other RA patients treated without anti-TNF therapy did not differ from that observed in the non-RA patients. Five patients died during hospitalization. The in-hospital mortality of the RA patients did not differ significantly from that of the non-RA patients. Independent factors contributing to in-hospital mortality did not include RA.
CONCLUSION: In this study, the RA patients treated without anti-TNF therapy did not differ from the non-RA patients in terms of the rate of extrapulmonary tuberculosis or bilateral pulmonary lesions, although they did exhibit a higher frequency of side effects of antituberculosis treatment. RA was not found to be an independent factor contributing to in-hospital mortality.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24930647     DOI: 10.2169/internalmedicine.53.1936

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents.

Authors:  Giovana Garziera; André Luis Bittencourt Morsch; Felipe Otesbelgue; Fernanda Luiza Staub; Penélope Esther Palominos; Claiton Viegas Brenol; Denise Rossato Silva
Journal:  Clin Rheumatol       Date:  2017-06-06       Impact factor: 2.980

Review 2.  Latent tuberculosis infection in patients with rheumatic diseases.

Authors:  Camila Anton; Felipe Dominguez Machado; Jorge Mario Ahumada Ramirez; Rafaela Manzoni Bernardi; Penélope Esther Palominos; Claiton Viegas Brenol; Fernanda Carvalho de Queiroz Mello; Denise Rossato Silva
Journal:  J Bras Pneumol       Date:  2019-04-25       Impact factor: 2.624

3.  Therapeutic issues with, and long-term outcomes of, pulmonary mycobacterial tuberculosis treatment in patients with autoimmune rheumatic diseases.

Authors:  Dong Won Park; Sung Jun Chung; Yoomi Yeo; Tai Sun Park; Hyun Lee; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Ho Joo Yoon; Jang Won Sohn
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

4.  Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.

Authors:  Lamia Oulkadi; Samira Rostom; Ihsane Hmamouchi; Salma El Hassani Sbai; Imane El Binoune; Bouchra Amine; Redouane Abouqal; Fadoua Allali; Lahsen Achemlal; Imane El Bouchti; Abdellah El Maghraoui; Imad Ghozlani; Hasna Hassikou; Taoufik Harzy; Linda Ichchou; Ouafae Mkinsi; Redouane Niamane; Rachid Bahiri
Journal:  Rheumatol Int       Date:  2021-06-26       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.